Narrow search
Showing 1 - 10 of 1,437
Cover Image
Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV: A Systematic Review for Low- and Middle-Income Countries
Galárraga, Omar Galrraga; Wirtz, Veronika J.; … - In: PharmacoEconomics 29 (2011) 7, pp. 579-599
As antiretroviral treatment (ART) for HIV/AIDS is scaled up globally, information on per-person costs is critical to improve efficiency in service delivery and to maximize coverage and health impact. The objective of this study was to review studies on unit costs for delivery of adult and...
Persistent link: https://www.econbiz.de/10011005080
Cover Image
Economic Considerations Related to Providing Adequate Pain Relief for Women in Labour: Comparison of Epidural and Intravenous Analgesia
Huang, Cecil; Macario, Alex - In: PharmacoEconomics 20 (2002) 5, pp. 305-318
Epidural analgesia and intravenous analgesia with opioids are two techniques for providing pain relief for women in labour. Labour pain is comparable to surgical pain in its severity, and epidural analgesia provides better relief from this pain than intravenous analgesia; a meta-analysis...
Persistent link: https://www.econbiz.de/10005243169
Cover Image
Consumer Preference for Dinoprostone Vaginal Gel Using Stated Preference Discrete Choice Modelling
Taylor, Susan J.; Armour, Carol L. - In: PharmacoEconomics 21 (2003) 10, pp. 721-735
Objective: To assess consumer preference for two methods of induction of labour using stated preference discrete choice modelling. The methods of induction were artificial rupture of the membranes (ARM) plus oxytocin and dinoprostone (prostaglandin E2) vaginal gel, followed by oxytocin if...
Persistent link: https://www.econbiz.de/10004990359
Cover Image
Relative Cost Effectiveness of Depo-Provera(R), Implanon(R), and Mirena(R) in Reversible Long-Term Hormonal Contraception in the UK
Varney, Susan J.; Guest, Julian F. - In: PharmacoEconomics 22 (2004) 17, pp. 1141-1151
resource utilisation values and contraception continuation rates were obtained from the GPRD. The incidence of pregnancy … pregnancy (Lstg 21 Conclusion: Long-acting reversible hormonal contraception has the benefit of being extremely effective (>99 … medical history and the estimated cost of an unintended pregnancy. Choice of contraception is essential to meet diverse user …
Persistent link: https://www.econbiz.de/10005449121
Cover Image
Chlamydia trachomatis in Adolescents and Adults: Clinical and Economic Implications
Marra, Carlo A.; Patrick, David M.; Reynolds, Robert; … - In: PharmacoEconomics 13 (1998) 2, pp. 191-222
The aim of this article is to provide an overview of the epidemiology, diagnosis, screening and pharmacotherapy of Chlamydia trachomatis infections in adolescents and adults, together with a critical review of economic studies published on this topic. C. trachomatis continues to produce enormous...
Persistent link: https://www.econbiz.de/10005449226
Cover Image
Economic Analysis of Long Term Reversible Contraceptives: Focus on Implanon(R)
Phillips, Ceri J. - In: PharmacoEconomics 18 (2000) 5, pp. 511-513
Persistent link: https://www.econbiz.de/10005449306
Cover Image
Economic Analysis of Long Term Reversible Contraceptives: Focus on Implanon(R)
Phillips, Ceri J. - In: PharmacoEconomics 17 (2000) 2, pp. 209-221
(R), and is also more cost effective in terms of cost per pregnancy avoided and cost per protected year than Norplant …
Persistent link: https://www.econbiz.de/10005404865
Cover Image
Economic Analysis of Long Term Reversible Contraceptives: Focus on Implanon(R)
Rissanen, Pekka - In: PharmacoEconomics 18 (2000) 5, pp. 511-513
Persistent link: https://www.econbiz.de/10005590311
Cover Image
Do Productivity Costs Matter?: The Impact of Including Productivity Costs on the Incremental Costs of Interventions Targeted at Depressive Disorders
Krol, Marieke; Papenburg, Joc; Koopmanschap, Marc; … - In: PharmacoEconomics 29 (2011) 7, pp. 601-619
Background:Background: When guidelines for health economic evaluations prescribe that a societal perspective should be adopted, productivity costs should be included. However, previous research suggests that, in practice, productivity costs are often neglected. This may considerably bias the...
Persistent link: https://www.econbiz.de/10011005068
Cover Image
Is There a Role for Pharmacoeconomics in Developing Countries?
Harper, Jonathan R. - In: PharmacoEconomics 29 (2011) 5, pp. 435-436
Persistent link: https://www.econbiz.de/10011005069